Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jul;40(3):399-411.
doi: 10.5534/wjmh.210146. Epub 2022 Jan 1.

The Role of Mitochondrial Dynamic Dysfunction in Age-Associated Type 2 Diabetes

Affiliations
Review

The Role of Mitochondrial Dynamic Dysfunction in Age-Associated Type 2 Diabetes

Teresa Vezza et al. World J Mens Health. 2022 Jul.

Abstract

Mitochondrial dynamics, such as fusion and fission, play a critical role in maintaining cellular metabolic homeostasis. The molecular mechanisms underlying these processes include fusion proteins (Mitofusin 1 [MFN1], Mitofusin 2 [MFN2], and optic atrophy 1 [OPA1]) and fission mediators (mitochondrial fission 1 [FIS1] and dynamin-related protein 1 [DRP1]), which interact with each other to ensure mitochondrial quality control. Interestingly, defects in these proteins can lead to the loss of mitochondrial DNA (mtDNA) integrity, impairment of mitochondrial function, a severe alteration of mitochondrial morphology, and eventually cell death. Emerging evidence has revealed a causal relationship between dysregulation of mitochondria dynamics and age-associated type 2 diabetes, a metabolic disease whose rates have reached an alarming epidemic-like level with the majority of cases (59%) recorded in men aged 65 and over. In this sense, fragmentation of mitochondrial networks is often associated with defects in cellular energy production and increased apoptosis, leading, in turn, to excessive reactive oxygen species release, mitochondrial dysfunction, and metabolic alterations, which can ultimately contribute to β-cell dysfunction and insulin resistance. The present review discusses the processes of mitochondrial fusion and fission and their dysfunction in type 2 diabetes, with special attention given to the therapeutic potential of targeting mitochondrial dynamics in this complex metabolic disorder.

Keywords: Aging; Men; Mitochondria; Type 2 diabetes.

PubMed Disclaimer

Conflict of interest statement

The authors have nothing to disclose.

Figures

Fig. 1
Fig. 1. Physiological mitochondrial dynamics: fusion and fission. When mitochondria fuse, their matrix materials intermix, creating elongated organelles. Mitofusin (MFN) 1 and 2 orchestrate mitochondrial fusion of the outer mitochondrial membrane (OMM), while fusion of the inner mitochondrial membrane (IMM) is mediated by optic atrophy 1 (OPA1) protein. Specifically, the C-terminal coiled-coil region of Mfn1 and Mfn2 mediates tethering between mitochondria through homo- or heterotypic complexes formed between adjacent mitochondria and OPA1 helps to maintain mitochondrial cristae morphology. A cytosolic dynamin-related protein 1 (DRP1) and fission protein 1 (FIS1) mediate mitochondrial fission. The process begins when DRP1 molecules are activated and move from the cytosol to the OMM, where they assemble and form a ring-shaped structure that constricts the mitochondrial tubule in order to mediate fission. Integral mitochondrial dynamics protein 51 kD (MiD51) and mitochondrial dynamics protein 49 kD (MiD49), along with MFF and FIS1, act as receptors that recruit DRP1 to the mitochondrial surface. ER: endoplasmic reticulum.
Fig. 2
Fig. 2. Mitochondrial dynamics, fission and fusion is critical for maintaining several cellular mechanisms such as cell apoptosis, reactive oxygen species (ROS) generation and energy production. Hyperglycaemia has been shown to induce mitochondrial fragmentation in type 2 diabetes (T2D), along with increased mitochondrial fission and reduced fusion. This figure shows some potential compounds that target mitochondrial dynamics, and the underlying mechanisms by which they may be an effective strategy to prevent the development and progression of T2D. FA: fatty acids, mdivi-1: mitochondrial division inhibitor-1, DRP1: dynamin-related protein 1, FIS1: fission protein 1, MFN: Mitofusin, OPA1: optic atrophy 1.

References

    1. Khan SS, Singer BD, Vaughan DE. Molecular and physiological manifestations and measurement of aging in humans. Aging Cell. 2017;16:624–633. - PMC - PubMed
    1. Kautzky-Willer A, Harreiter J, Pacini G. Sex and gender differences in risk, pathophysiology and complications of type 2 diabetes mellitus. Endocr Rev. 2016;37:278–316. - PMC - PubMed
    1. Cho NH, Shaw JE, Karuranga S, Huang Y, da Rocha Fernandes JD, Ohlrogge AW, et al. IDF diabetes atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018;138:271–281. - PubMed
    1. Kalyani RR, Golden SH, Cefalu WT. Diabetes and aging: unique considerations and goals of care. Diabetes Care. 2017;40:440–443. - PMC - PubMed
    1. Burhans MS, Hagman DK, Kuzma JN, Schmidt KA, Kratz M. Contribution of adipose tissue inflammation to the development of type 2 diabetes mellitus. Compr Physiol. 2018;9:1–58. - PMC - PubMed